Cat: PAX2000-10471

Recombinant Human pp9099 Protein,His

  • Price
  • Size
  • Number

    Order now. For delivery time, please consult customer service

  • Pre-sale guidance and worry-free after-sale service
  • Quality assurance for cold chain transportation

Analytical Data

  • Gene name

    pp9099

  • Application

    SPRMSTBLIITCELISACELL ASSAYDRUG SCREENING

  • Alternative Names

    AI840980; DKFZp761K2312; FLJ38884; MGC30448; PH domain containing protein homolog; PH domain-containing family O member 2; PH domain-containing family Q member 1; PKHO2_HUMAN; Pleckstrin homology domain containing family O member 2; Pleckstrin homology domain containing family Q member 1; Pleckstrin homology domain-containing family O member 2; Pleckstrin homology domain-containing family Q member 1; PLEKHO2; PLEKHQ1; PP1628; pp9099; RGD1305718

  • Species

    Human

  • Source

    E. coli

  • Tag

    His tag N-Terminus

  • Purity

    Greater than 90% as determined by SDS-PAGE.

  • Uniprot

    Q8TD55

  • Expression Region

    1-490 aa

  • AA Sequence

    MEEEGVKEAG EKPRGAQMVD KAGWIKKSSG GLLGFWKDRY LLLCQAQLLV YENEDDQKCV ETVELGSYEK CQDLRALLKR KHRFILLRSP GNKVSDIKFQ APTGEEKESW IKALNEGINR GKNKAFDEVK VDKSCALEHV TRDRVRGGQR RRPPTRVHLK EVASAASDGL LRLDLDVPDS GPPVFAPSNH VSEAQPRETP RPLMPPTKPF LAPETTSPGD RVETPVGERA PTPVSASSEV SPESQEDSET PAEEDSGSEQ PPNSVLPDKL KVSWENPSPQ EAPAAESAEP SQAPCSETSE AAPREGGKPP TPPPKILSEK LKASMGEMQA SGPPAPGTVQ VSVNGMDDSP EPAKPSQAEG TPGTPPKDAT TSTALPPWDL PPQFHPRCSS LGDLLGEGPR HPLQPRERLY RAQLEVKVAS EQTEKLLNKV LGSEPAPVSA ETLLSQAVEQ LRQATQVLQE MRDLGELSQE APGLREKRKE LVTLYRRSAP

  • Molecular Weight

    53.3 kDa

  • Endotoxin

    < 1.0 EU per μg protein as determined by the LAL method.

  • Form

    Freeze-dried powder

  • Buffer formulation

    PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.

  • Reconstitution

    Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.

  • Customization

    Site-directed mutagenesis Custom tag design Custom buffer formulation Custom full-length protein production

  • Stability Test

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.

  • Storage & Shelf Life

    Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.

  • Shipping

    In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.

Quality inspection process

Related Products

Protein Description

The PP9099 recombinant protein has garnered attention in the field of molecular biology and biotechnology due to its potential applications in therapeutic development and drug design. Initially identified as part of a larger family of proteins involved in various cellular processes, PP9099 has demonstrated unique structural properties that make it a candidate for further exploration. Research indicates that this protein may play a role in essential biological pathways, potentially influencing cell signaling, immune response, and metabolic regulation. The recombinant version of PP9099 is produced using recombinant DNA technology, allowing for the generation of large quantities of the protein for in-depth studies. The expressiveness of this protein in various model systems enables researchers to investigate its functional attributes and interactions. As studies continue to unveil the biochemical properties and mechanisms of PP9099, its implications for understanding diseases at the molecular level, particularly those related to metabolic disorders and autoimmune conditions, are becoming increasingly evident. Furthermore, the study of PP9099 could pave the way for novel therapeutic strategies, including the development of protein-based drugs or biologics that could modulate its activity in pathological states. Hence, ongoing research efforts are aimed at elucidating the exact mechanisms by which PP9099 operates within the cellular context, ultimately contributing to a greater understanding of its role in health and disease.

E-mail

sales@ipodix.com

Sales

+1 2092920560


Contact us via WhatsApp

IPODIX Biotech Inc

2108 N ST, STE N
Sacramento, CA 95816, USA

For Product Information and Orders

sales@ipodix.com

For Business Collaboration

sales@ipodix.com

For CRO Services

sales@ipodix.com

For Technical Support

sales@ipodix.com
  • 50000+

    Recombinant Proteins

  • 100+

    Researchers

  • 100+

    Countries Served

  • ISO

    Certified Quality

Committed to Quality
Driven by Innovation

Learn More About US